We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Capillary and Venous Lactate Compared in ED Patients

By LabMedica International staff writers
Posted on 16 Apr 2019
Print article
Image: The Automatic QC RAPID Systems RAPIDPoint 500 blood gas analyzer (Photo courtesy of Siemens Healthcare).
Image: The Automatic QC RAPID Systems RAPIDPoint 500 blood gas analyzer (Photo courtesy of Siemens Healthcare).
Elevated lactate levels are a common finding in acutely unwell patients. Blood lactate level is a good predictor of patient outcome and high lactate levels are associated with high morbidity and mortality. Lactate may be detected and measured in all blood samples: arterial, venous and capillary.

Currently, blood lactate can be measured formally in the laboratory, using blood gas analyzers or with handheld devices. Strong correlations have been shown between blood lactate levels in samples analyzed in the central laboratory, by blood gas analyzers and handheld devices. Capillary blood lactate testing with handheld analyzers has great advantages to reduce the time needed for clinical decisions, and for extended use in the prehospital setting.

Emergency department (ED) personnel at the Chinese University of Hong Kong (Shatin, Hong Kong) and their colleagues carried out a prospective observational study of patients presenting to the ED of Prince of Wales Hospital (Shatin, Hong Kong) and 240 patients (mean age 69.9 years) were recruited. Venous and capillary blood samples were collected for lactate analysis. Venous blood samples (approximate 1 mL) were collected by venipuncture while capillary blood samples were collected by finger-prick with a disposable lancet.

Venous lactate levels were measured by blood gas analyzer the Siemens Automatic QC RAPID Systems RAPIDPoint 500 (VL-Ref) served as the reference standard. Capillary lactate levels were immediately analyzed by two handheld lactate analyzers: Nova StatStrip Xpress Lactate Meter (CL-Nova) and Lactate Scout+ (CL-Scout). Venous lactate levels were also measured on the two handheld lactate analyzers. All lactate measurements were performed within 15 minutes after obtaining the venous sample.

The scientists reported that the results of VL-Ref ranged from 0.70 to 5.38 mmol/L (mean of 1.96 mmol/L). Regarding capillary lactate measurements, the bias (mean difference) between VL-Ref and CL-Scout+ was −0.22 with 95% limits of agreement (LOA) of −2.17 to 1.73 mmol/L and the bias between VL-Ref and CL-Nova was 0.46, with LOA of −1.08 to 2.00 mmol/L. For venous lactate, results showed the bias between VL-Ref and VL-Scout+ were 0.22 with LOA being −0.46 to 0.90 mmol/L, and the bias between VL-Ref and VL-Nova was 0.83 mmol/L with LOA −0.01 to 1.66 mmol/L.

The author concluded that their study shows poor agreement between capillary lactate and reference values. The study does not support the clinical utility of capillary lactate point-of-care testing (POCT). However, venous lactate measured by Scout+ handheld analyzer may have potential for screening patients who may need further testing. The study was published on April 3, 2019, in the journal BMJ OPEN.

Related Links:
Chinese University of Hong Kong
Prince of Wales Hospital

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
New
Pipet Controller
Stripettor Pro

Print article

Channels

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.